Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Method-for-recovery-of-refined-alpha-galactosidase

 Method for recovery of refined .alpha.-galactosidase

Details
Inventors: Yamada, Masaru; Furuya, Tsutomu; Izumi, Chikashi; Narita, Shigeyoshi; Ishikawa, Hiroshi;
Assignee: Hokkaido Sugar Co., Ltd. (Tokyo, JA)
Primary Examiner: Shapiro; Lionel M.
Assistant Examiner:
Attorney, Agent or Firm: Oblon, Fisher, Spivak, McClelland & Maier

A method for the recovery of refined .alpha.-galactosidase is disclosed. This method comprises the steps of bringing an .alpha.-galactosidase-containing liquid into contact with a weakly acidic cation-exchange resin in the presence of a buffer solution for thereby allowing .alpha.-galactosidase to be selectively adsorbed by said resin, desorbing the adsorbed .alpha.-galactosidase from said resin by use of a buffer solution of a type such that at least one of the two factors, concentration and pH, has a higher value than that of the buffer solution used in said adsorption and thereafter recovering the desorbed .alpha.-galactosidase.

DETAILED DESCRIPTION OF THE INVENTION The methods heretofore suggested for the refinement of .
alpha.
-galactosidase suffer from various disadvantages such as poor recovery ratio, insufficient purity and complication of operation.
With a view to overcoming the difficulties, the inventors pursued various studies in search of a new method capable of advantageous recovery of .
alpha.
-galactosidase.
They developed a hypothesis that recovery of .
alpha.
-galactosidase of high purity ought to be obtained easily by causing .
alpha.
-galactosidase to be selectively adsorbed by means of an ion-exchange resin capable of specifically combining the .
alpha.
-galactosidase.
They tested ion-exchange resins to single out one which would qualify for the purpose.
They have, consequently, made a discovery that the weakly acidic cation-exchange resin specifically provides adsorption of the .
alpha.
-galactosidase in the presence of a buffer solution under stated conditions and permits desorption thereof by use of a buffer solution satisfying a specific requirement.
The present invention has been acomplished on the basis of this discovery.
As the .
alpha.
-galactosidase-containing liquid to be subjected to the treatment by the method of this invention, there can be used either the .
alpha.
-galactosidase-containing culture broth obtained by culturing any of the known .
alpha.
-galactosidase-producing microorganisms or the .
alpha.
-galactosidase-containing liquid obtained by extracting the .
alpha.
-galactosidase contained in frozen microorganic cells or dry microorganic cells.
The concentration of .
alpha.
-galactosidase in the broth or liquid makes little difference.
Particularly in the case of the .
alpha.
-galactosidase which is formed by the culture of molds, since the enzyme occurs for the most part within the cells of the molds, the .
alpha.
-galactosidase is extracted from the cells by physically or chemical treating the cells.
The extract consequently obtained is put to the treatment.
The ion-exchange resin to be used in the method of this invention is a weakly acidic cation-exchange resin of which examples are Amberlite IRC-50, IRC-75, IRC-84, CG-50 (products of Rohm and Hass company of the USA), Duolite CS-101, CS-100 (products of Diamond Alkali Co



Related patents
  Antimicrobial composition containing Type II endoglycosidase and antimicrobial agent
The invention provides antimicrobial methods utilizing Type II endoglycosidases such as endo-.beta.-N-acetylglucosaminidase ("Endo") H, D, F and/or PNGase F alone or in ...
  Wound healing composition of IGF-I and TGF-.beta.
We claim: 1. A method for healing an external wound of a mammal comprising applying to said wound a wound-healing amount of a composition consisting essentially or ...
  Flowable demineralized bone powder composition and its use in bone repair
What is claimed is: 1. A flowable composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth-inducing ...
  Crosslinkable polypeptide compositions
OF THE INVENTION In accordance with the present invention, there are provided chemically modified polypeptides having the formula: P--(A--C(O)--Y).sub.n wherein: P is ...

0.024

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved